Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04160546Phase 2Completed
Study to Evaluate the Reinduction and Second Stop of TKI With Ponatinib in CML in Molecular Response (ResToP)
Chronic Myeloid Leukemia, Chronic Phase
PrincipalinvestigatorStart date: 2020-01-17

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Hospital Universitario 12 de Octubre

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Juan Carlos Hernández Boluda, MD

Hospital Clínico de Valencia

Related
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveChronic Myeloid Leukemia, Chronic Phase

Worked with same sponsors:

Apices Soluciones S.L.Fundacion CRIS de Investigación para Vencer el Cáncer+1 more
Collaborated on 1 trial
Similarity Score24%

Valentín García Gutierrez, MD

Hospital Universitario Ramon y Cajal

Related
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveChronic Myeloid Leukemia, Chronic Phase

Worked with same sponsors:

Apices Soluciones S.L.Fundacion CRIS de Investigación para Vencer el Cáncer+1 more
Collaborated on 1 trial
Similarity Score24%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score15%

K A Bradstock), Dr.

Westmead Hospital

Related
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score15%

J Szer, Dr.

Royal Melbourne Hospital, Parkville, Australia

Related
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score15%

E Gluckman, Dr.

Hopital St Louis, Paris, France

Related
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score15%

J Rowe, Dr.

Rambam Medical Center, Haifa, Israel

Related
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score15%

G Lambertenghi-Deliliers, Dr.

Padiglione G Marcora, Ospedale Maggiore di Milano, Italy

Related
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score15%

T Ruutu, Dr.

Helsinki University CT. Rentral Hospital, Finland

Related
1 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score15%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04160546Phase 2PrincipalInvestigator

Study to Evaluate the Reinduction and Second Stop of TKI With Ponatinib in CML in Molecular Response (ResToP)

Chronic Myeloid Leukemia, Chronic Phase
Completed

All 1 trials loaded